EBRUMA Trademark

Trademark Overview

On Tuesday, March 3, 2020, a trademark application was filed for EBRUMA with the United States Patent and Trademark Office. The USPTO has given the EBRUMA trademark a serial number of 88818835. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 25, 2023. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The EBRUMA trademark is filed in the Pharmaceutical Products category with the following description:

antivirals
ebruma

General Information

Serial Number88818835
Word MarkEBRUMA
Filing DateTuesday, March 3, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements

Goods and Servicesantivirals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, September 25, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 25, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 6, 2023SOU EXTENSION 5 GRANTED
Monday, January 30, 2023SOU EXTENSION 5 FILED
Monday, January 30, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 12, 2023ASSIGNED TO EXAMINER
Thursday, July 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 19, 2022SOU EXTENSION 4 GRANTED
Tuesday, July 19, 2022SOU EXTENSION 4 FILED
Tuesday, July 19, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 8, 2022SOU EXTENSION 3 GRANTED
Tuesday, February 1, 2022SOU EXTENSION 3 FILED
Tuesday, February 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 1, 2022SOU TEAS EXTENSION RECEIVED
Saturday, August 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 5, 2021SOU EXTENSION 2 GRANTED
Thursday, August 5, 2021SOU EXTENSION 2 FILED
Thursday, August 5, 2021SOU TEAS EXTENSION RECEIVED
Thursday, February 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 9, 2021SOU EXTENSION 1 GRANTED
Tuesday, February 9, 2021SOU EXTENSION 1 FILED
Tuesday, February 9, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, May 17, 2020ASSIGNED TO EXAMINER
Monday, March 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 6, 2020NEW APPLICATION ENTERED

Related Keywords

ebruma antivirals